AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (June 20, 2003). doi:10.1152/ajplung.00102.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/4/L940    most recent
00102.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Savov, J. D.
Right arrow Articles by Schwartz, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Savov, J. D.
Right arrow Articles by Schwartz, D. A.
Submitted on April 7, 2003
Accepted on June 20, 2003

FIBRINOLYSIS IN LPS INDUCED CHRONIC AIRWAY DISEASE

Jordan D. Savov1*, David M. Brass1, Katherine G. Berman1, Erin McElvania1, and David A. Schwartz2

1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, NC, USA
2 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, NC, USA; VA Medical Center, Durham, NC, USA

* To whom correspondence should be addressed. E-mail: jsavov{at}duke.edu.

To examine the role of the fibrinolytic system in lipopolysaccharide (LPS) induced airway disease, we compared the affect of a chronic LPS challenge in plasminogen activator inhibitor deficient (C57BL/6JPAI-1-/-) mice and wild-type (WT) C57BL/6J mice. Physiologic and biologic assessments were performed before (n=24), immediately after (n=12), and 4 wk after (n=12) the end of an 8 wk exposure to either LPS or saline (control). Immediately following the 8 week LPS exposure, WT mice had increased estimates of airway reactivity to methacholine when compared to C57BL/6JPAI-1-/- mice, however, airway inflammation was similar in both C57BL/6JPAI-1-/- and WT LPS exposed groups. Significant increases in both active TGF-{beta}1 and active MMP-9 was detected following LPS exposure in WT mice but not in C57BL/6JPAI-1-/- mice. C57BL/6JPAI-1-/- animals showed significantly less TGF-{beta}1 (total and active) in the lavage and higher MMP-9 in the lung tissue than WT mice at the end of the exposure as well as 4 wk later. Following LPS exposure, both WT and C57BL/6JPAI-1-/- mice had substantial expansion of the subepithelial area of the medium (d=90-129µm) and large (d>129µm) size airways when compared to saline-exposed mice. Subepithelial fibrin deposition was prevalent in WT mice, but greatly diminished in C57BL/6JPAI-1-/-. PAI-1 expression by non-ciliated bronchial epithelial cells was enhanced in the airways of LPS exposed WT mice when compared to the saline-exposed group. Four weeks following inhalation of LPS the increased airway reactivity and the expansion of the subepithelial area in the medium and large size airways persisted in WT mice, but not in the C57BL/6JPAI-1-/- mice. We conclude that an active fibrinolytic system can substantially alter the development and resolution of the postinflammatory airway remodeling that is observed following chronic inhalation of LPS.




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. M. Brass, J. W. Hollingsworth, M. Cinque, Z. Li, E. Potts, E. Toloza, W. M. Foster, and D. A. Schwartz
Chronic LPS Inhalation Causes Emphysema-Like Changes in Mouse Lung that Are Associated with Apoptosis
Am. J. Respir. Cell Mol. Biol., November 1, 2008; 39(5): 584 - 590.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
B. D. Sachs, G. S. Baillie, J. R. McCall, M. A. Passino, C. Schachtrup, D. A. Wallace, A. J. Dunlop, K. F. MacKenzie, E. Klussmann, M. J. Lynch, et al.
p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway
J. Cell Biol., July 30, 2007; 177(6): 1119 - 1132.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
D. M. Brass, J. Tomfohr, I. V. Yang, and D. A. Schwartz
Using Mouse Genomics to Understand Idiopathic Interstitial Fibrosis
Proceedings of the ATS, January 1, 2007; 4(1): 92 - 100.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. D. Savov, D. M. Brass, B. L. Lawson, E. McElvania-Tekippe, J. K. L. Walker, and D. A. Schwartz
Toll-like receptor 4 antagonist (E5564) prevents the chronic airway response to inhaled lipopolysaccharide
Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L329 - L337.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Rojas, C. R. Woods, A. L. Mora, J. Xu, and K. L. Brigham
Endotoxin-induced lung injury in mice: structural, functional, and biochemical responses
Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L333 - L341.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.